Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial
Titel:
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial
Auteur:
de Alarcon, Pedro A Matthay, Katherine K London, Wendy B Naranjo, Arlene Tenney, Sheena C Panzer, Jessica A Hogarty, Michael D Park, Julie R Maris, John M Cohn, Susan L